Will a CT (Computed Tomography) scan of the abdomen and pelvis show retained fragments after a miscarriage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A CT scan of the abdomen and pelvis is not the preferred imaging method for detecting retained fragments after a miscarriage, and its ability to show retained fragments is limited, as noted in studies such as 1 and 1. When considering the detection of retained products of conception (RPOC) after a miscarriage, it's essential to prioritize imaging methods that provide detailed visualization of the uterine cavity while minimizing risks and costs.

  • Transvaginal ultrasound is the recommended first-line imaging technique due to its superior ability to visualize the uterine cavity, safety profile, lack of radiation exposure, lower cost, and widespread availability, as implied by the context of studies like 1 and 1.
  • CT scans, on the other hand, use ionizing radiation and, while they can detect larger tissue fragments or complications like hemorrhage or infection, they provide less detailed images of the uterine cavity compared to ultrasound, as suggested by 1. If retained tissue is suspected after a miscarriage, patients should seek medical attention promptly as complications like bleeding or infection may develop.
  • The healthcare provider will likely order a transvaginal ultrasound first, and only consider a CT scan if there are specific concerns about complications outside the uterus or if ultrasound results are inconclusive, based on the principles outlined in studies such as 1 and 1. Treatment for retained tissue may include expectant management, medication (such as misoprostol), or a minor surgical procedure called dilation and curettage (D&C) depending on the amount of tissue and symptoms, reflecting a balanced approach that considers morbidity, mortality, and quality of life, as would be informed by recent and high-quality studies like those referenced here 1.

From the Research

CT Scan for Retained Fragments

  • A CT scan of the abdomen and pelvis can be used to identify abdominopelvic hemorrhage, but its effectiveness in showing retained fragments after a miscarriage is not directly addressed in the provided studies 2.
  • However, studies suggest that transvaginal sonography is a useful supplement to clinical assessment in women who experience a spontaneous first-trimester abortion, and it can help detect retained products of conception 3.
  • The use of misoprostol for medical management of retained products of conception after miscarriage has been studied, and it has been shown to be effective in avoiding surgical intervention in some cases 4, 5, 6.
  • It is not clear if a CT scan would be the best imaging modality for detecting retained fragments after a miscarriage, as ultrasound and transvaginal sonography are more commonly used for this purpose 5, 3.

Detection of Retained Products of Conception

  • Transvaginal sonography has been shown to have high sensitivity and specificity for detecting retained products of conception after first-trimester spontaneous abortion 3.
  • The use of misoprostol for medical management of retained products of conception has been shown to be effective in avoiding surgical intervention in some cases, but it may not be effective in all cases 4, 5, 6.
  • The detection of retained products of conception is important to prevent complications such as infection and bleeding, and imaging modalities such as ultrasound and transvaginal sonography can play a crucial role in this detection 5, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.